- Home
- NTB vs BCRX Comparison
NTB vs BCRX Comparison
Compare NTB & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTB
- BCRX
- Stock Information
- Founded
- NTB 1858
- BCRX 1986
- Country
- NTB Bermuda
- BCRX United States
- Employees
- NTB N/A
- BCRX N/A
- Industry
- NTB Commercial Banks
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTB Finance
- BCRX Health Care
- Exchange
- NTB Nasdaq
- BCRX Nasdaq
- Market Cap
- NTB 1.9B
- BCRX 1.8B
- IPO Year
- NTB 2016
- BCRX 1994
- Fundamental
- Price
- NTB $45.17
- BCRX $7.70
- Analyst Decision
- NTB Buy
- BCRX Strong Buy
- Analyst Count
- NTB 3
- BCRX 10
- Target Price
- NTB $51.33
- BCRX $16.70
- AVG Volume (30 Days)
- NTB 161.5K
- BCRX 2.3M
- Earning Date
- NTB 10-21-2025
- BCRX 11-03-2025
- Dividend Yield
- NTB 4.43%
- BCRX N/A
- EPS Growth
- NTB 14.60
- BCRX N/A
- EPS
- NTB 4.96
- BCRX N/A
- Revenue
- NTB $588,897,000.00
- BCRX $557,506,000.00
- Revenue This Year
- NTB $3.31
- BCRX $41.37
- Revenue Next Year
- NTB N/A
- BCRX $7.56
- P/E Ratio
- NTB $9.12
- BCRX N/A
- Revenue Growth
- NTB 2.95
- BCRX 45.85
- 52 Week Low
- NTB $34.77
- BCRX $6.02
- 52 Week High
- NTB $46.89
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- NTB 51.86
- BCRX 29.84
- Support Level
- NTB $44.50
- BCRX $7.93
- Resistance Level
- NTB $45.67
- BCRX $8.13
- Average True Range (ATR)
- NTB 0.82
- BCRX 0.21
- MACD
- NTB 0.05
- BCRX -0.05
- Stochastic Oscillator
- NTB 72.52
- BCRX 2.00
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.